Check Cap (CHEK) Hits New 52-Week Low at $3.08
Check Cap Ltd (NASDAQ:CHEK) shares reached a new 52-week low during mid-day trading on Friday . The company traded as low as $3.08 and last traded at $3.17, with a volume of 200 shares changing hands. The stock had previously closed at $3.12.
A number of research analysts have issued reports on the company. Zacks Investment Research raised Check Cap from a “hold” rating to a “buy” rating and set a $3.75 target price for the company in a research note on Monday, August 6th. HC Wainwright set a $14.00 target price on Check Cap and gave the company a “buy” rating in a research note on Wednesday, August 1st.
Check Cap (NASDAQ:CHEK) last posted its quarterly earnings data on Friday, August 10th. The medical research company reported ($0.70) earnings per share for the quarter, topping the consensus estimate of ($0.82) by $0.12. sell-side analysts forecast that Check Cap Ltd will post -2.6 EPS for the current fiscal year.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface.
Featured Story: Price to Earnings Ratio (PE)
Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.